Scenario 1: Optimizing Management of Acute GVHD
Experts review the prognosis of a patient with acute graft-versus-host disease and identify ways to optimize their treatment strategies.
Scenario 1: Selecting Therapy for Acute Graft-Versus-Host Disease
A panel of experts discuss systemic therapy to manage a patient with acute graft-versus-host disease.
Scenario 1: Acute GVHD Symptomology and Patient Education
Centering discussion on a patient scenario of acute graft-versus-host disease, participants discuss nuance in disease symptomology and patient education.
Virtual Tumor Board®: An Overview on Graft-Versus-Host Disease and Prophylaxis
Expert perspectives on the nature and occurrence of graft-versus-host disease alongside available prophylactic regimens.
Exploring the Implications of the ROCKstar Regimen in Chronic GVHD
Corey S. Cutler, MD, MPH, FRCPC, discusses the trial of belumosudil in patients with chronic graft-vs-host disease.
Future Directions and Unmet Needs in Chronic GvHD
Emerging Agents for the Treatment of Chronic GvHD
Steroid-Refractory GvHD: Treatment With JAK Inhibitors
Treatment Options for Chronic GvHD
Definition of GvHD
Case Overview: 49-Year-Old Man With Chronic GvHD
A 49-Year-Old Man With Steroid-Refractory Chronic Graft Versus Host Disease
Corey S. Cutler, MD, MPH, FRCPC, provides insight on the case of a 49-year-old man with chronic GVHD and reviews current and emerging treatment options for disease management.
Steroid-Refractory Chronic GVHD Requires More Treatment Options
Corey S. Cutler, MD, MPH, discusses the current treatment options for patients with chronic graft-versus-host-disease and highlighted some upcoming research.
2 Commerce Drive Cranbury, NJ 08512